ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 38579751

Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence.

McGlone ER and 2 others. J Endocrinol, 2024. Cited by 23 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence. Papers, record 38579751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38579751

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Glucagon resistance and metabolic-associated steatotic liver disease: a review of the evidence.
PubMed
Journal
J Endocrinol
PubMed
Year
2024
PubMed
Publication types
Review, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
23
iCite
Relative citation ratio, by iCite
3.44, provisional
iCite
Revised in PubMed
2026-09-22
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1McGlone EREmma Rosehttps://orcid.org/0000-0002-0968-6972
2Bloom SRStephen R
3Tan TMTricia M-Mhttps://orcid.org/0000-0001-5873-3432

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlucagonMajor topic
Fatty LiverMajor topic
Humans
Obesity
Fibroblast Growth Factors
Liver
Glucagon-Like Peptide 1
Animals

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References140

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116,843,380Regulation of urea synthesis by glucose and glucagon in normal man.Clin Nutr1994https://conductscience.org/library/papers/16843380PubMed
221,270,251Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice.Diabetes2011https://conductscience.org/library/papers/21270251PubMed
337,078,380Postprandial dysfunction in fatty liver disease.Physiol Rep2023https://conductscience.org/library/papers/37078380PubMed
424,062,250Fibroblast growth factor 21 (FGF21) and glucagon-like peptide 1 contribute to diabetes resistance in glucagon receptor-deficient mice.Diabetes2014https://conductscience.org/library/papers/24062250PubMed
531,260,026Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.JAMA Intern Med2019https://conductscience.org/library/papers/31260026PubMed
628,648,835Effect of GLP-1 receptor agonist on gastrointestinal tract motility and residue rates as evaluated by capsule endoscopy.Diabetes Metab2017https://conductscience.org/library/papers/28648835PubMed
733,239,450Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia.Diabetes2021https://conductscience.org/library/papers/33239450PubMed
835,718,339Hepatocyte cholesterol content modulates glucagon receptor signalling.Mol Metab2022https://conductscience.org/library/papers/35718339PubMed
934,271,220Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling.Mol Metab2021https://conductscience.org/library/papers/34271220PubMed
1031,979,106Global Transcriptomic Analysis of Zebrafish Glucagon Receptor Mutant Reveals Its Regulated Metabolic Network.Int J Mol Sci2020https://conductscience.org/library/papers/31979106PubMed

1 to 10 of 140

See all 140 references

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.

PMIDTitleJournalYearIn PapersSource
42,923,173Berberine and metabolic dysfunction-associated steatotic liver disease: a global analysis of molecular mechanisms, translational challenges and research frontiers.Front Nutr2026https://conductscience.org/library/papers/42923173PubMed
42,481,773Regulation and clinical manifestations of gluconeogenesis dysfunction.NPJ Metab Health Dis2026https://conductscience.org/library/papers/42481773PubMed
42,285,749Amino acids partially override inhibitory effects of octreotide on islet hormone secretion in healthy individuals.J Physiol2026https://conductscience.org/library/papers/42285749PubMed
42,072,319Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review.Biomedicines2026https://conductscience.org/library/papers/42072319PubMed
41,931,030Increased Early Postprandial Glucagon Concentrations in Humans With Newly Diagnosed Type 2 Diabetes and Steatotic Liver Disease.Diabetes Care2026https://conductscience.org/library/papers/41931030PubMed
41,910,843Hypothalamus-liver talks: whispers in the language of metabolism.Rev Endocr Metab Disord2026https://conductscience.org/library/papers/41910843PubMed
41,264,848Hypothalamic Prostaglandins Facilitate Recovery From Severe Hypoglycemia but Exacerbate Recurrent Hypoglycemia in Mice.Diabetes2025https://conductscience.org/library/papers/41264848PubMed
41,150,819Study on Autophagy Death of Alpha TC1 Clone 6 (αTC1-6) Cells Induced by Trametenolic Acid Through PI3K/AKT Pathway.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41150819PubMed
40,995,421Pharmacotherapy for Obesity: Recent Updates.Clin Pharmacol2025https://conductscience.org/library/papers/40995421PubMed
40,776,973Efficacy of Dual Glucagon and Glucagon-like Peptide-1 Receptor Agonists Across the Cardiometabolic Continuum: A Review of Current Clinical Evidence.Rev Cardiovasc Med2025https://conductscience.org/library/papers/40776973PubMed

1 to 10 of 13

See all 13 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FGF2126,291PubTator's text mininghttps://conductscience.org/library/genes/26291NCBI Gene
GCG2,641PubTator's text mininghttps://conductscience.org/library/genes/2641NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38579751

GET https://conductscience.org/api/papers/v1/38579751/references?page=2

API referenceFor AI assistants